세계의 백신 전달 기기 시장 규모 : 디바이스별, 투여 경로별, 최종사용자별, 지역 범위별 및 예측

Global Vaccine Delivery Devices Market Size By Devices, By Route Of Administration, By End-User, By Geographic Scope And Forecast

US $ 3,950 ￦ 5,457,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 4,850 ￦ 6,701,000

PDF & Excel (5 User License)

PDF 및 Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 7,550 ￦ 10,431,000

PDF & Excel (Enterprise User License)

PDF 및 Excel 보고서를 동일기업내 모든 분들이 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

한글목차

백신 전달 기기 시장 규모 및 예측

백신 전달 기기 시장 규모는 2024년 49억 9,000만 달러로 평가되었고, 2026-2032년 연평균 8.5% 성장하여 2032년에는 88억 3,000만 달러에 달할 것으로 예측됩니다.

• 백신 전달 기기는 백신 투여를 위해 특별히 고안된 도구 및 기술입니다. 이러한 장비는 정확한 투여, 안전한 전달, 감염성 질환에 대한 적절한 예방접종을 보장하기 위해 의료 전문가와 개인에게 필수적입니다.
• 백신 전달 기기는 병원, 진료소, 의원 등 의료 시설에서 소아 예방접종 일정, 계절성 독감 예방접종 캠페인, 기타 예방 의료 이니셔티브를 포함한 정기적인 예방접종 프로그램을 위해 일반적으로 사용됩니다.
• 특히 의료 서비스에 대한 접근성이 제한되어 있는 농촌 지역이나 의료 서비스가 부족한 지역에서는 백신 전달 기기가 지역 보건 프로그램 및 아웃리치 활동에서 중요한 역할을 하고 있습니다.
• 최신 백신 전달 기술 중 하나인 무침주사는 집단 예방접종 프로그램에서 효과적으로 사용되고 있습니다. 이는 바늘에 찔리는 부상과 한 바늘을 여러 번 사용하는 데 따른 합병증 가능성을 줄이는 데 도움이 됩니다.
• 또한, 기타 백신 전달 기기에는 제트 주사기, 일회용 주사기, 마이크로니들, 피내 전달 장치 등이 있습니다. 이들은 모두 불활성화 소아마비 백신 전달에 사용됩니다.

세계의 백신 전달 기기 시장 역학

백신 전달 기기 시장을 형성하는 주요 시장 역학은 다음과 같습니다.

주요 시장 성장 촉진요인

• 강력한 연구 개발: 세계 제품 공급 증가는 풍토병 퇴치를 위한 백신 접종 프로그램 시장 확대를 촉진하고 있습니다. 정부, 병원, 제약회사는 정기적이고 저렴한 백신 접종을 장려하고 있으며, 정부의 적극적인 감시를 통해 모든 사람이 최소한의 비용으로 백신 접종을 받을 수 있도록 하고 있습니다.
• 헬스케어 분야에서의 예방접종 범위 확대: 백신 전달 장비에 대한 수요는 예방접종 범위를 확대하고, 예방접종에 대한 접근성을 높이기 위한 노력에 의해 주도되고 있으며, 정부, 의료기관, NGO가 협력하여 중저소득 국가의 예방접종률을 높이기 위한 노력을 하고 있습니다. 중저소득국가의 예방접종률 향상을 목표로 하고 있습니다.
• 정부의 의료비 지출 증가: 백신 전달 기기에 대한 수요는 예방접종률을 높이고, 백신 접종률을 높이고, 의료 서비스를 받지 못하는 사람들에게 백신을 공급하기 위한 정부 주도의 노력과 의료 기관 및 NGO의 협력에 의해 촉진되고 있습니다.
• 기술 발전: 바늘에 찔리는 부상, 오염된 바늘로 인한 감염, 부적절하게 멸균된 바늘로 인한 혈액 매개 감염 등의 위험으로 인해 바늘을 사용하지 않는 전달 장치에 대한 수요가 급증하고 있습니다. 시장 성장의 원동력은 새로운 전달 기술에 대한 주요 기업, 국제기구, 연구기관의 관심입니다.
• 예를 들어, 2022년 1월 화이자와 Acuitas Therapeutics는 mRNA 백신 및 치료제를 위해 특별히 설계된 지질 나노입자 전달 시스템을 개발하기 위해 협력하기로 했습니다. 이번 제휴는 양사의 전문성을 활용하여 mRNA 기반 치료제와 백신의 전달 효율성과 효능을 향상시키는 것을 목표로 하고 있습니다.

주요 과제

• 높은 백신 접종 비용: 만성질환 및 감염성 질환의 발병률 증가가 시장 성장의 원동력이 되고 있습니다. 그러나 백신 1회 접종과 관련된 높은 비용이 시장 확대의 걸림돌로 작용하고 있습니다. 국제기구는 전 세계에 수백만 회 분량의 백신을 공급하고 있지만, 높은 비용으로 인해 아직 많은 지역에서 백신 접종이 이루어지지 않고 있습니다.
• 인프라 문제: 백신 공급망은 효능을 유지하기 위해 엄격한 온도 관리가 필요합니다. 농촌이나 외딴 지역 등 콜드체인 인프라가 열악한 지역에서는 이러한 관리가 어려워 백신의 효능이 떨어지고 백신 공급 장비에 대한 수요가 감소할 수 있습니다.
• 의료 인력 역량 문제: 숙련된 의료 인력의 부족은 백신의 적절한 투여를 방해하고, 투여 지연, 투여 실수, 전달 장치의 부적절한 취급을 초래하며, 적절한 전달 장치가 있더라도 전체 예방 접종 결과에 영향을 미칩니다.
• 백신 공급망의 혼란: 제조 지연, 유통 병목 현상, 물류 문제 등 백신 공급망의 혼란은 백신 공급 장비의 가용성 및 접근성에 영향을 미칠 가능성이 높습니다. 자연재해, 지정학적 긴장, 공중보건 비상사태 등으로 인한 공급망 중단은 예방접종 프로그램을 방해하고 백신 전달 장비의 배치를 제한할 수 있습니다.

주요 동향 :

• 무통 투여: 환자의 편안함과 수용성을 높이기 위해 무통 백신 투여법 개발에 대한 관심이 높아지고 있습니다. 마이크로니들 패치와 같은 기술은 통증이 적은 저침습적 피부 천자를 통해 백신을 전달하는 것으로, 특히 소아 및 노년층에게 기존의 주사바늘을 이용한 방법보다 장점이 있을 수 있습니다.
• 스마트 주사기: 센서 및 연결 기능을 갖춘 스마트 주사기 등 백신 전달 기기에 디지털 헬스 기술을 통합하여 백신 투여의 실시간 모니터링, 투여량 추적, 백신 접종 일정 준수를 가능하게 합니다. 이러한 기기는 데이터 수집을 용이하게 하고, 환자 참여를 강화하며, 원격 환자 모니터링을 지원합니다.
• 생분해성 및 친환경 소재: 지속가능성과 환경 책임에 대한 관심이 높아짐에 따라 백신 전달 기기에는 생분해성 및 친환경 소재가 채택되고 있습니다. 제조업체들은 환경에 미치는 영향을 줄이고 순환 경제의 원칙을 촉진하기 위해 바이오플라스틱, 퇴비화 가능한 재료 등 기존 플라스틱을 대체할 수 있는 재료를 찾고 있습니다.

목차

제1장 세계의 백신 전달 기기 시장 서론

• 시장 서론
• 조사 범위
• 전제조건

제2장 주요 요약

제3장 VERIFIED MARKET RESEARCH의 조사 방법

• 데이터 마이닝
• 밸리데이션
• 1차 자료
• 데이터 소스 리스트

제4장 세계의 백신 전달 기기 시장 전망

• 개요
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• Porter's Five Forces 모델
• 밸류체인 분석

제5장 세계의 백신 전달 기기 시장 : 디바이스별

• 개요
• 주사기
• 제트 인젝터

제6장 세계의 백신 전달 기기 시장 : 투여 경로별

• 개요
• 피내 백신 접종
• 근육내 백신 접종
• 피하 백신 접종

제7장 세계의 백신 전달 기기 시장 : 최종사용자별

• 개요
• 병원 및 진료소
• 재택치료
• 외래수술센터(ASC)

제8장 세계의 백신 전달 기기 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타 아시아태평양
• 세계 기타 지역
  • 라틴아메리카
  • 중동 및 아프리카

제9장 세계의 백신 전달 기기 시장 경쟁 구도

• 개요
• 기업의 시장 순위
• 주요 개발 전략

제10장 기업 개요

• 3M
• Becton Dickinson & Company
• Gerresheimer AG
• Bioject Medical Technologies, Inc.(Inovio Pharmaceutical Inc.)
• SCHOTT AG
• Valeritas
• PharmaJet
• Vaxxas
• Corium International, Inc

제11장 부록

• 관련 조사

LSH

영문 목차

영문목차

Vaccine Delivery Devices Market Size And Forecast

Vaccine Delivery Devices Market size was valued at USD 4.99 Billion in 2024 and is projected to reach USD 8.83 Billion by 2032, growing at a CAGR of 8.5% from 2026-2032.

• Vaccine delivery devices are tools and technologies specifically designed for the administration of vaccines. These devices are essential for healthcare professionals and individuals to ensure accurate dosage, safe delivery, and proper immunization against infectious diseases.
• Vaccine delivery devices are commonly used in healthcare facilities such as hospitals, clinics, and medical offices for routine immunization programs, including childhood vaccination schedules, seasonal flu vaccination campaigns, and other preventive healthcare initiatives.
• Vaccine delivery devices play a crucial role in community health programs and outreach efforts, particularly in rural or underserved areas where access to healthcare services may be limited.
• One of the latest vaccine delivery technologies, such as needle-free options, is effectively used in mass immunization programs. It helps to reduce the chances of needle stick injuries and the complications associated with the multiple uses of a single needle.
• Moreover, other vaccine delivery devices include jet injectors, disposable syringes, microneedles, and intradermal delivery devices. These are all used for the delivery of inactivated poliovirus vaccines.

Global Vaccine Delivery Devices Market Dynamics

The key market dynamics that are shaping the Vaccine Delivery Devices Market include:

Key Market Drivers:

• Robust Research and Development: The global increase in product supply is facilitating market expansion for vaccination programs aimed at eradicating endemic diseases. Governments, hospitals, and pharmaceutical corporations are promoting routine and affordable vaccinations, with active government surveillance ensuring everyone receives them at minimal cost.
• Expanded Immunization Coverage in Healthcare Sector: The demand for vaccine delivery devices is driven by efforts to expand immunization coverage and reach underserved populations, with collaboration between governments, healthcare organizations, and NGOs aiming to improve vaccination rates in low- and middle-income countries.
• Rising Healthcare Expenditure by Government: The demand for vaccine delivery devices is fueled by government-led initiatives to enhance immunization coverage and reach underserved populations, facilitated by collaborations between healthcare organizations and NGOs.
• Technological Advancements: The demand for needle-free delivery is surging due to the risks of needle stick injuries, infection from contaminated needles, and blood-borne infections from improperly sterilized needles. The market growth is expected to be driven by interest from key players, international organizations, and institutions in novel delivery technologies.
• For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics joined forces to develop a lipid nanoparticle delivery system that is specifically designed for mRNA vaccines and therapeutics. This collaboration aims to leverage the expertise of both companies to enhance the delivery efficiency and effectiveness of mRNA-based treatments and vaccines.

Key Challenges:

• High Costs of Vaccine Dose: The growing incidence of chronic and infectious diseases is driving market growth. However, high costs associated with the per-dose vaccine volume are hampering market expansion. Though international organizations are supplying millions of volume doses around the globe, many parts are yet to receive vaccination due to their high cost.
• Infrastructure Challenges: The supply chain of vaccines requires strict temperature control to maintain their potency. In regions with inadequate cold chain infrastructure, such as rural or remote areas, this becomes challenging, potentially compromising vaccine effectiveness and decreasing demand for vaccine delivery devices.
• Healthcare Workforce Capacity Challenges: A shortage of trained healthcare workers is hindering the proper administration of vaccines, leading to delays, dosage errors, and improper handling of delivery devices, affecting overall immunization outcomes, even with adequate delivery devices available.
• Disruptions in the Vaccine Supply Chain: Supply chain disruption such as manufacturing delays, distribution bottlenecks, and logistics challenges, is likely to impact the availability and accessibility of vaccine delivery devices. Supply chain disruptions, whether due to natural disasters, geopolitical tensions, or public health emergencies, may disrupt immunization programs and limit the deployment of vaccine delivery devices.

Key Trends:

• Painless Administration: There is growing interest in developing painless vaccine delivery methods to enhance patient comfort and acceptance. Technologies such as microneedle patches, which deliver vaccines through painless, minimally invasive skin punctures, offer potential advantages over traditional needle-based injections, particularly for pediatric and geriatric populations.
• Smart Injection Devices: Integration of digital health technologies into vaccine delivery devices, such as smart injection devices equipped with sensors and connectivity features, allows for real-time monitoring of vaccination administration, dosage tracking, and adherence to vaccination schedules. These devices facilitate data collection, enhance patient engagement, and support remote patient monitoring.
• Biodegradable and Eco-Friendly Materials: Increasing emphasis on sustainability and environmental responsibility drives the adoption of biodegradable and eco-friendly materials in vaccine delivery devices. Manufacturers are exploring alternatives to conventional plastics, such as bioplastics and compostable materials, to reduce environmental impact and promote circular economy principles.

Global Vaccine Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Vaccine Delivery Devices Market:

North America:

• North America has established regulatory frameworks for healthcare products, including vaccine delivery devices, overseen by agencies like the FDA and Health Canada. These standards ensure safety, efficacy, and quality, boosting consumer confidence and market growth.
• The region is at the forefront of technological innovation in healthcare, including vaccine delivery devices. Advancements such as needle-free injectors, auto-disable syringes, and smart injection devices improve vaccine administration, enhance patient comfort, and optimize immunization outcomes.
• North America is home to several key market players, including pharmaceutical companies, medical device manufacturers, and healthcare technology firms. These companies drive innovation, research, and development in vaccine delivery devices, introducing new products and technologies to the market.

Europe:

• Europe places a strong emphasis on healthcare quality and safety, driving the adoption of advanced healthcare technologies and best practices. Vaccine delivery devices must meet high standards of safety, reliability, and performance to ensure patient well-being and public health outcomes.
• European governments provide support for vaccination programs through funding, policy development, and public health campaigns. National vaccination schedules, recommendations, and incentives encourage vaccination uptake and drive demand for vaccine delivery devices across healthcare settings.
• European countries continue to invest in healthcare infrastructure, research and development, and innovation to improve healthcare delivery and patient outcomes. Investments in vaccination programs, including the procurement of vaccine delivery devices, contribute to market growth and innovation in the region.

Asia Pacific:

• Asia Pacific is home to some of the world's most populous countries, including China and India. The sheer size of the population creates a substantial demand for vaccines and vaccine delivery devices to address healthcare needs.
• Economic growth in many countries across the Asia Pacific region has led to increased healthcare spending. Governments and private sectors are investing more in healthcare infrastructure, including vaccination programs and the procurement of vaccine delivery devices.
• There is a growing awareness among individuals and communities in the Asia Pacific about the importance of preventive healthcare measures, including vaccination. Public health campaigns, educational initiatives, and advocacy efforts contribute to increased vaccination uptake and demand for vaccine-delivery devices.
• Emerging economies in Asia Pacific, such as China, India, Indonesia, and Vietnam, offer significant growth opportunities due to their large populations and increasing investments in healthcare infrastructure. These countries are witnessing rapid urbanization, economic development, and healthcare reforms, driving demand for healthcare products and services, including vaccine delivery devices.

Global Vaccine Delivery Devices Market: Segmentation Analysis

The Global Medical Sensors Market is Segmented on the basis of Devices, Route Of Administration, End-User, And Geography.

Vaccine Delivery Devices Market, By Devices

• Syringes
• Jet Injectors

Based on Devices, The market is segmented into Syringes and Jet Injectors. Among these, syringes are expected to dominate the market as they provide flexibility in administering various vaccinations, including liquid and lyophilized vaccines (which are freeze-dried and need to be reconstituted before use). Syringes can be used in various immunization situations. However, the jet injectors segment of the Vaccine Delivery Devices Market is expanding at the quickest rate.

Vaccine Delivery Devices Market, By Route Of Administration

• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination

Based on Route Of Administration, The market is segmented into Intradermal, Intramuscular, and Subcutaneous. The largest market segment is intradermal, which enhances immunogenicity by interacting directly with skin-derived immune cells. Intramuscular, the most rapidly growing segment, is recommended for administering a wide range of vaccinations, booster shots, and routine immunizations to individuals of all ages due to its versatility.

Vaccine Delivery Devices Market, By End-User

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgery Centers

Based on End-User, The market is segmented into Hospitals & clinics, Home Care Settings, and Ambulatory Surgery Centers. Hospitals typically account for the majority share in the end-user segment of the Vaccine Delivery Devices Market. Hospitals often serve as centralized hubs for vaccination services, providing a wide range of vaccines to patients across various age groups and medical conditions. Academic medical centers and research hospitals play a key role in vaccine research, clinical trials, and medical education. They utilize vaccine delivery devices for research purposes, vaccine trials, and training healthcare professionals.

Key Players

The "Global Vaccine Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet, Vaxxas, and Corium International, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

• Vaccine Delivery Devices Market, Recent Developments
• In March 2022, The National Institute of Allergy and Infectious Diseases (NIAID) initiated a clinical trial to evaluate three experimental HIV vaccines. These vaccines are developed using a messenger RNA (mRNA) platform, which has been previously used in multiple Covid-19 vaccines that have been approved.
• In April 2023, the FDA approved CSL's immunoglobulin pre-filled syringe, Hizentra, for use in treating patients with chronic inflammatory demyelinating conditions. Primary Immunodeficiency (PI) and Polyneuropathy (CIDP). The injection offers convenient drug delivery and is ready for use.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VACCINE DELIVERY DEVICES MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL VACCINE DELIVERY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY DEVICES

• 5.1 Overview
• 5.2 Syringes
• 5.3 Jet Injectors

6 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

• 6.1 Overview
• 6.2 Intradermal Vaccination
• 6.3 Intramuscular Vaccination
• 6.4 Subcutaneous Vaccination

7 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals & Clinics
• 7.3 Home Care Settings
• 7.4 Ambulatory Surgery Centers

8 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 3M
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Becton Dickinson & Company
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Gerresheimer AG
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 SCHOTT AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Valeritas
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 PharmaJet
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Vaxxas
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Corium International, Inc
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research

관련자료